Abstract |
Granulocyte colony-stimulating factor ( G-CSF) administration in vivo has been shown to improve the defence mechanisms against infection by different microbes. Here we evaluated a possible protective role of this molecule in a mouse model of mycobacterial infection. The administration of recombinant G-CSF promoted an extensive blood neutrophilia but failed to improve the course of Mycobacterium avium infection in C57Bl/6 or beige mice. G-CSF administration also failed to improve the efficacy of a triple chemotherapeutic regimen ( clarithromycin + ethambutol + rifabutin). G-CSF treatment did not protect interleukin-10 gene disrupted mice infected with M. avium. Spleen cells from infected mice treated with G-CSF had a decreased priming for antigen-specific production of interferon gamma compared to control infected mice. Our data do not substantiate previous reports on the protective activity of G-CSF in antimycobacterial immunity using mouse models.
|
Authors | A S Gonçalves, R Appelberg |
Journal | Clinical and experimental immunology
(Clin Exp Immunol)
Vol. 124
Issue 2
Pg. 239-47
(May 2001)
ISSN: 0009-9104 [Print] England |
PMID | 11422200
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimicrobial Cationic Peptides
- Antitubercular Agents
- Blood Proteins
- Recombinant Proteins
- neutrophil basic proteins
- Interleukin-10
- Granulocyte Colony-Stimulating Factor
- Rifabutin
- Interferon-gamma
- Ethambutol
- Clarithromycin
|
Topics |
- Animals
- Antimicrobial Cationic Peptides
- Antitubercular Agents
(therapeutic use)
- Blood Proteins
- Clarithromycin
(therapeutic use)
- Ethambutol
(therapeutic use)
- Female
- Granulocyte Colony-Stimulating Factor
(therapeutic use)
- Interferon-gamma
(metabolism)
- Interleukin-10
(metabolism)
- Mice
- Mice, Inbred C57BL
- Mycobacterium avium
- Neutrophils
(cytology)
- Recombinant Proteins
- Rifabutin
(therapeutic use)
- Tuberculosis
(drug therapy)
|